Skip to main content
Top
Published in: Cardiovascular Ultrasound 1/2008

Open Access 01-12-2008 | Research

Appropriateness of carotid plaque and intima-media thickness assessment in routine clinical practice

Authors: Liz Andréa Villela Baroncini, Aguinaldo de Oliveira, Enrique Antonio Vidal, Graciliano José França, Paulo Sérgio Dalla Bona Stahlke, Alexandre Alessi, Dalton Bertolim Précoma

Published in: Cardiovascular Ultrasound | Issue 1/2008

Login to get access

Abstract

Objectives

To describe the findings and evaluate appropriateness of a carotid artery study including the measurement of IMT, the presence of atherosclerotic plaque, and their correlation with cardiovascular risk factors.

Methods

555 patients (220 men; 67.06 ± 12.44 years) were included in the study. 120 patients (21.62%) presented carotid plaque: 108 (19.45%) in patients with at least one risk factor and 12 (2.1%) in patients without risk factors. With respect to appropriateness of the present studies: 65% were appropriate, 22% were uncertain and 13% were inappropriate. The IMT medians were higher in males (0.0280; 95% CI, 00.82 to 0.478; p = 0.0057) and in hypertensive patients (0.391; 95% CI, 0.0190 to 0.0592; p = 0,001). There was a linear increase in mean IMT for each year increased in age (0.0059; 95% CI; 0.0050 to 0.0067). Carotid plaque was more frequent in patients with CAD (p = 0.0002), diabetes (p = 0.024) and hypertension (p = 0.036).

Conclusion

Assessment of carotid arteries identified increased incidence of plaque in patients with CAD, diabetes and hypertension. IMT was increased in older patients, hypertensive patients and males. Forty-five percent of the patients were studied based on uncertain and inappropriate reasons.
Appendix
Available only for authorised users
Literature
1.
go back to reference Benedetto FA, Mallamaci F, Tripepi G, Zoccali C: Prognostic value of ultrasonographic measurement of carotid intima-media thickness in dialysis patients. J Am Soc Nephrol. 2001, 12: 2458-2464.PubMed Benedetto FA, Mallamaci F, Tripepi G, Zoccali C: Prognostic value of ultrasonographic measurement of carotid intima-media thickness in dialysis patients. J Am Soc Nephrol. 2001, 12: 2458-2464.PubMed
2.
go back to reference Gepner AD, Keevil JG, Wyman RA, Korcarz CE, Aeschlimann SE, Busse KL, et al.: Use of carotid intima-media thickness and vascular age to modify cardiovascular risk prediction. J Am Soc Echocardiogr. 2006, 19: 1170-1174.CrossRefPubMed Gepner AD, Keevil JG, Wyman RA, Korcarz CE, Aeschlimann SE, Busse KL, et al.: Use of carotid intima-media thickness and vascular age to modify cardiovascular risk prediction. J Am Soc Echocardiogr. 2006, 19: 1170-1174.CrossRefPubMed
3.
go back to reference Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Desvarieux M, et al.: Mannheim intima-media thickness Consensus. Cerebrovasc Dis. 2004, 18: 346-349.CrossRefPubMed Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Desvarieux M, et al.: Mannheim intima-media thickness Consensus. Cerebrovasc Dis. 2004, 18: 346-349.CrossRefPubMed
4.
go back to reference Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, et al.: ASE Consensus Statement. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography. Carotid Intima Media-Thickness Task Force endorsed by the Society of Vascular Medicine. J Am Soc Echocardiogr. 2008, 21: 93-111.CrossRefPubMed Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, et al.: ASE Consensus Statement. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography. Carotid Intima Media-Thickness Task Force endorsed by the Society of Vascular Medicine. J Am Soc Echocardiogr. 2008, 21: 93-111.CrossRefPubMed
5.
go back to reference Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein L, et al.: Mannheim carotid intima-media thickness consensus. Cerebrovasc Dis. 2007, 23: 75-80.CrossRefPubMed Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein L, et al.: Mannheim carotid intima-media thickness consensus. Cerebrovasc Dis. 2007, 23: 75-80.CrossRefPubMed
6.
go back to reference Hurst RT, NG DWC, Kendall C, Khandheria B: Clinical use of carotid intima-media thickness: review of the literature. Echocardiogra. 2007, 20: 907-914. 10.1016/j.echo.2007.02.028.CrossRef Hurst RT, NG DWC, Kendall C, Khandheria B: Clinical use of carotid intima-media thickness: review of the literature. Echocardiogra. 2007, 20: 907-914. 10.1016/j.echo.2007.02.028.CrossRef
7.
go back to reference Potter K, Reed CJ, Green DJ, Hankey GJ, Arnolda LF: Ultrasound settings significantly alter arterial lumen and wall thickness measurements. Cardiovascular Ultrasound. 2008, 6: 6-CrossRefPubMedPubMedCentral Potter K, Reed CJ, Green DJ, Hankey GJ, Arnolda LF: Ultrasound settings significantly alter arterial lumen and wall thickness measurements. Cardiovascular Ultrasound. 2008, 6: 6-CrossRefPubMedPubMedCentral
8.
go back to reference Toikka JO, Laine H, Ahotupa M, Haapanen A, Viikari JSA, Hartiala JJ, et al.: Increased arterial intima-media thickness and in vivo LDL oxidation in young men with borderline hypertension. Hypertension. 2000, 36: 929-933.CrossRefPubMed Toikka JO, Laine H, Ahotupa M, Haapanen A, Viikari JSA, Hartiala JJ, et al.: Increased arterial intima-media thickness and in vivo LDL oxidation in young men with borderline hypertension. Hypertension. 2000, 36: 929-933.CrossRefPubMed
9.
go back to reference Barenbrock M, Hausberg M, Kosch M, Golubev SA, Kisters K, Rahn KH: Flow-mediated vasodilatation and distensibility in relation to intima-media thickness of large arteries in mild essential hypertension. Am J Hypertens. 1999, 12: 973-979.CrossRefPubMed Barenbrock M, Hausberg M, Kosch M, Golubev SA, Kisters K, Rahn KH: Flow-mediated vasodilatation and distensibility in relation to intima-media thickness of large arteries in mild essential hypertension. Am J Hypertens. 1999, 12: 973-979.CrossRefPubMed
10.
go back to reference Cromheeke KM, Kockx MM, De Meyer GRY, Bosmans JM, Bult H, Beelaerts WJF, et al.: Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/perioxidation in human atherosclerotic plaques. Cardiovascular Research. 1999, 43: 744-754.CrossRefPubMed Cromheeke KM, Kockx MM, De Meyer GRY, Bosmans JM, Bult H, Beelaerts WJF, et al.: Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/perioxidation in human atherosclerotic plaques. Cardiovascular Research. 1999, 43: 744-754.CrossRefPubMed
11.
go back to reference Thakory AH, Guo CY, Larson MG, Corey D, Wang TJ, Vasan RS, D'Agostino RB, Lipinska I, Keaney JF, Benjamin EJ, O'Donnell CJ: Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol. 2007, 99: 1598-1602.CrossRef Thakory AH, Guo CY, Larson MG, Corey D, Wang TJ, Vasan RS, D'Agostino RB, Lipinska I, Keaney JF, Benjamin EJ, O'Donnell CJ: Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol. 2007, 99: 1598-1602.CrossRef
12.
go back to reference Mustafa A, Walls J: End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?. Kidney International. 2001, 59: 407-414.CrossRef Mustafa A, Walls J: End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?. Kidney International. 2001, 59: 407-414.CrossRef
13.
go back to reference Damas JK, Waehre T, Yndestad A, Gullestad L, Aukrust P: Atherosclerotic plaque stabilization – potential role of immunomodulatory therapy. Vascular Disease Prevention. 2004, 1: 17-31. 10.2174/1567270043480832.CrossRef Damas JK, Waehre T, Yndestad A, Gullestad L, Aukrust P: Atherosclerotic plaque stabilization – potential role of immunomodulatory therapy. Vascular Disease Prevention. 2004, 1: 17-31. 10.2174/1567270043480832.CrossRef
14.
go back to reference Fujisawa M, Haramaki R, Miyasaki H, Imaizumi T, Okusa S: Role of lipoprotein (a) and TGF-β1 in atherosclerosis of haemodialysis patients. J Am Soc Nephrol. 2000, 11: 1889-1895.PubMed Fujisawa M, Haramaki R, Miyasaki H, Imaizumi T, Okusa S: Role of lipoprotein (a) and TGF-β1 in atherosclerosis of haemodialysis patients. J Am Soc Nephrol. 2000, 11: 1889-1895.PubMed
15.
go back to reference Shishehbor M, Bhatt DL: Inflammation and atherosclerosis. Current Atherosclerosis Reports. 2004, 6: 131-139.CrossRefPubMed Shishehbor M, Bhatt DL: Inflammation and atherosclerosis. Current Atherosclerosis Reports. 2004, 6: 131-139.CrossRefPubMed
16.
go back to reference Gosling J, Slaymaker S, Gu L, Tseng S, Zlot CH, Young SG, Rollins BJ, Charo IF: MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest. 1990, 103: 773-778. 10.1172/JCI5624.CrossRef Gosling J, Slaymaker S, Gu L, Tseng S, Zlot CH, Young SG, Rollins BJ, Charo IF: MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest. 1990, 103: 773-778. 10.1172/JCI5624.CrossRef
17.
go back to reference Lombardo A, Biasucci LM, Lanza AG, Coli S, Silvestri P, Cianflone D, Liuzzo G, Burzotta F, Crea F, Maseri A: Inflammation as a possible link between coronary and carotid plaque instability. Circulation. 2004, 109: 3158-3163.CrossRefPubMed Lombardo A, Biasucci LM, Lanza AG, Coli S, Silvestri P, Cianflone D, Liuzzo G, Burzotta F, Crea F, Maseri A: Inflammation as a possible link between coronary and carotid plaque instability. Circulation. 2004, 109: 3158-3163.CrossRefPubMed
18.
go back to reference Lee WY, Allison MA, Kim DJ, Song CH, Barret-Connor E: Association of interleukin-6 and C-reactive protein with subclinical carotid atherosclerosis (the Rancho Bernardo Study). Am J Cardiol. 2007, 99: 99-102.CrossRefPubMed Lee WY, Allison MA, Kim DJ, Song CH, Barret-Connor E: Association of interleukin-6 and C-reactive protein with subclinical carotid atherosclerosis (the Rancho Bernardo Study). Am J Cardiol. 2007, 99: 99-102.CrossRefPubMed
19.
go back to reference Crouse JR, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Bots ML: Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis. JAMA. 2007, 297: 1344-1353.CrossRefPubMed Crouse JR, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Bots ML: Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis. JAMA. 2007, 297: 1344-1353.CrossRefPubMed
20.
go back to reference Langenfeld MR, Forst T, Hohberg C, Kann P, Lübben G, Konrad T, Füllert SD, Sachara C, Pfützner A: Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: result from a controlled randomized study. Circulation. 2005, 111: 2525-2531.CrossRefPubMed Langenfeld MR, Forst T, Hohberg C, Kann P, Lübben G, Konrad T, Füllert SD, Sachara C, Pfützner A: Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: result from a controlled randomized study. Circulation. 2005, 111: 2525-2531.CrossRefPubMed
21.
go back to reference Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM: Effect of very high-intensity statin therapy on regression of coronary atherosclerosis. The Asteroid Trial. JAMA. 2006, 295: 1556-1565.CrossRefPubMed Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM: Effect of very high-intensity statin therapy on regression of coronary atherosclerosis. The Asteroid Trial. JAMA. 2006, 295: 1556-1565.CrossRefPubMed
Metadata
Title
Appropriateness of carotid plaque and intima-media thickness assessment in routine clinical practice
Authors
Liz Andréa Villela Baroncini
Aguinaldo de Oliveira
Enrique Antonio Vidal
Graciliano José França
Paulo Sérgio Dalla Bona Stahlke
Alexandre Alessi
Dalton Bertolim Précoma
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Cardiovascular Ultrasound / Issue 1/2008
Electronic ISSN: 1476-7120
DOI
https://doi.org/10.1186/1476-7120-6-52

Other articles of this Issue 1/2008

Cardiovascular Ultrasound 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.